APA

Aronne L. J., Tonstad S., Moreno M., Gantz I., Erondu N., Suryawanshi S., Molony C., Sieberts S., Nayee J., Meehan A. G., Shapiro D., Heymsfield S. B., Kaufman K. D. & Amatruda J. M. (20101104). A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. : International journal of obesity (2005).

Chicago

Aronne L J, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan A G, Shapiro D, Heymsfield S B, Kaufman K D and Amatruda J M. 20101104. A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. : International journal of obesity (2005).

Harvard

Aronne L. J., Tonstad S., Moreno M., Gantz I., Erondu N., Suryawanshi S., Molony C., Sieberts S., Nayee J., Meehan A. G., Shapiro D., Heymsfield S. B., Kaufman K. D. and Amatruda J. M. (20101104). A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. : International journal of obesity (2005).

MLA

Aronne L J, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan A G, Shapiro D, Heymsfield S B, Kaufman K D and Amatruda J M. A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study. : International journal of obesity (2005). 20101104.